NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE125862 Query DataSets for GSE125862
Status Public on Jan 30, 2019
Title Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Methods: RNA-seq libraries were prepared using the Illumina TruSeq technology. The libraries were quantified and samples were multiplexed in each lane of the flowcell. Cluster generation was performed and then sequenced on the Illumina HiSeq2500 system. Reads were mapped on the Human Genome Reference (GRCh38) and normalized expression table was generated.
Results: Among differentially expressed genes, compared with DMSO-treated hiPSC-CMs, 505 genes were upregulated in FM+WY+TID-treated hiPSC-CMs, with 72 genes commonly upregulated in both FM+WY+TID-treated hiPSC-CMs and LV groups and 949 genes were downregulated in FM+WY+TID-treated hiPSC-CMs and 2137 genes were downregulated in LV, with 437 genes downregulated in both FM+WY+TID-treated hiPSC-CMs and LV compared with DMSO-treated hiPSC-CMs .
Conclusions: Data demonstrate increased expression of genes associated with many metabolic processes which are also highly enriched in human pediatric heart samples including many interconnected metabolic processes that are upstream of lipid metabolism and FAO, agreeing with the shift to FAO for energy utilization in more mature CMs, and decreased expression of genes involved in developmental processes, adhesion and signaling in both FM+WY+TID-treated hiPSC-CMs and LV. The overlap in both upregulated and downregulated genes in both groups confirmed an advanced degree of cardiomyocyte maturation in response to FM+WY+TID.
 
Overall design RNA-sequencing analysis was performed to compare global gene expression profiles of hiPSC-CMs at differentiation day 28 with maturation factors (FM+WY+TID) treatment (Treat) vs. DMSO treatment (DMSO) vs. left ventricle tissue sample (LV).
 
Contributor(s) Gentillon C, Li D, Duan M, Gibson GC, Xu C
Citation(s) 31082397
Submission date Jan 29, 2019
Last update date May 21, 2019
Contact name Dong Li
E-mail(s) dli50@emory.edu
Organization name Emory University
Department Pediatrics
Street address 2015 UPPERGATE DR
City ATLANTA
State/province GEORGIA
ZIP/Postal code 30322
Country USA
 
Platforms (1)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
Samples (9)
GSM3583613 DMSO_Replicate 1
GSM3583614 DMSO_Replicate 2
GSM3583615 DMSO_Replicate 3
Relations
BioProject PRJNA517720
SRA SRP182844

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE125862_DL_DESeq_LV_vs_DMSO.down.txt.gz 457.8 Kb (ftp)(http) TXT
GSE125862_DL_DESeq_LV_vs_DMSO.up.txt.gz 429.8 Kb (ftp)(http) TXT
GSE125862_DL_DESeq_Treat_vs_DMSO.down.txt.gz 95.7 Kb (ftp)(http) TXT
GSE125862_DL_DESeq_Treat_vs_DMSO.up.txt.gz 78.1 Kb (ftp)(http) TXT
GSE125862_DL_DESeq_Treat_vs_LV.down.txt.gz 422.9 Kb (ftp)(http) TXT
GSE125862_DL_DESeq_Treat_vs_LV.up.txt.gz 453.6 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap